carpal tunnel syndrome
Conditions
Interventions
Group A:MSN release combined with steroid injection
Group B:Steroid injection
Sponsors
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) pain, numbness or tingling in the median nerve distribution area of hand; 2) nocturnal worsening of the symptoms; 3) positive Tinel and/or Phalen sign; 4) slowing of the sensory conduction velocity and abnormal distal motor latency; 5) the desire of the participant to have either a steroid injection or MSN release.
Exclusion criteria
Exclusion criteria: 1) symptomatic CTS because of diabetes, thyroid disease or rheumatic disease; 2) cervical radiculopathy or other polyneuropathy; 3) age<18 years; 4) pregnancy; 5) previous steroid injection of CTS in the preceding 6 months; 6) history of wrist fracture; 7) prior carpal tunnel decompressive surgery; 8) the presence of infection or skin lesion at the site of injection; 9) refusal of informed consent or inability to participate in follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Boston carpal tunnel questionnaire (BCTQ);cross-sectional area of the median nerve (CSA);distal motor latency (DML);compound motor action potential (CMAP);sensory nerve action potential (SNAP);motor nerve conduction velocity (MNCV);sensory nerve conduction velocity (SNCV); | — |
Countries
China
Contacts
Public ContactMa Chao
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Outcome results
None listed